Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients

BACKGROUND: Low-dose post-transplant cyclophosphamide (PTCy) in conjunction with anti-thymocyte globulin (ATG) appears as a potentially effective graft-versus-host disease (GVHD) prevention strategy in haploidentical hematopoietic cell transplant (haplo-HCT). Our study aims to assess the efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yu, Wu, De-Pei, Liu, Qi-Fa, Xu, Lan-Ping, Liu, Kai-Yan, Zhang, Xiao-Hui, Yu, Wen-Jing, Xu, Yang, Huang, Fen, Huang, Xiao-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724335/
https://www.ncbi.nlm.nih.gov/pubmed/31481121
http://dx.doi.org/10.1186/s13045-019-0781-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724335/
https://www.ncbi.nlm.nih.gov/pubmed/31481121
http://dx.doi.org/10.1186/s13045-019-0781-y

Ejemplares similares